EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Watch-and-wait approach in high-risk locally advanced rectal cancer: outcomes after complete response to total neoadjuvant therapy

Evi Banken iD, Barbara M Geubels, Fleur E C Vande Kerckhove, Davy M J Creemers iD, Stijn H J Ketelaers, Joost Nederend, Heike M U Peulen, Irene E G van Hellemond, Harm J T Rutten, Jacobus W A Burger

BJS Open · 2025

DOI: 10.1093/bjsopen/zraf136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJS Open, 2025. Verfasst von Evi Banken und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Catharina Hospital, Eindhoven, The Netherlands. Hauptthemen laut MEDLINE: Rectal Neoplasms, Neoadjuvant Therapy, Watchful Waiting. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: ZonMw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In patients with the most advanced stages of high-risk locally advanced rectal cancer (LARC), extensive resections often lead to morbidity and functional impairment. It is unclear whether these patients, despite poor prognosis, are suitable candidates for a watch-and-wait (W&W) approach in cases of a clinical complete response (cCR).

Methods

Consecutive patients with high-risk LARC who underwent total neoadjuvant therapy (TNT), followed by surgery or a W&W approach between January 2016 and February 2023, were retrospectively analysed. High-risk features included tumour invasion into the mesorectal fascia, grade 4 extramural venous invasion, enlarged lateral lymph nodes, or tumour deposits. Patients were categorized into complete response (CR) or non-CR, and stratified by W&W and surgically treated. Outcomes were regrowth, local recurrence, distant metastases (DM), regrowth-free survival, organ survival, local recurrence-free survival (LRFS), distant metastasis-free survival (DMFS), recurrence-free survival (RFS) (all death-censored), and overall survival.

Results

Of 135 patients, 29 (21.5%) achieved a cCR and entered W&W. A total of 103 patients (78.0%) underwent immediate surgery, including 15 (11.1%) with a pathological CR. Median follow-up was 42 months (range 9–76) for CR patients versus 42.5 months (range 7–82) for non-CR patients. Local recurrence and DM occurred in 1 (2.3%) and 7 patients (15.9%) in the CR group, respectively, versus 14 (15.9%) and 21 patients (23.9%) in the non-CR group, respectively. Three-year death-censored LRFS and DMFS rates were 97.6% and 82.7% in the CR group, respectively, versus 85.8% and 76.0% in the non-CR group, respectively (P = 0.016, P = 0.273). Five-year overall survival was 89.5% in the CR group versus 84.0% in the non-CR group (P = 0.131). Median follow-up was 44 months (range 16–71) in W&W patients and 42 months (range 7–82) in surgically treated patients. Among W&W patients, regrowth occurred in seven patients (24.1%) and the 3-year death-censored regrowth-free survival was 79.2%. Three-year death-censored RFS and 5-year overall survival were 71.9% and 90.9% in W&W patients, respectively, versus 72.3% and 84.2% in surgically treated patients, respectively (P = 0.680, P = 0.115).

Conclusion

A W&W approach can be considered safe and feasible for patients with high-risk LARC. Achieving a CR after TNT is associated with favourable oncological outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsNeoadjuvant TherapyWatchful WaitingHumansMaleFemaleMiddle AgedRetrospective StudiesAgedNeoplasm Recurrence, LocalAdultNeoplasm StagingTreatment OutcomeDisease-Free SurvivalPrognosis

Stichwörter der Autor:innen

induction chemotherapyorgan preservationradiotherapyrectal cancer managementresponse assessment

Autor:innen und Institutionen

  • Department of Medical Oncology, Catharina Hospital, Eindhoven, The Netherlands.
  • Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.
  • GROW Research Institute for Oncology and Reproduction, Faculty of Health, Medicine and Life Science, Maastricht University, Maastricht, The Netherlands.
  • Department of Surgery, Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Department of Surgery, Maastricht Academic Medical Center, Maastricht, The Netherlands.
  • Department of Radiology, Catharina Hospital, Eindhoven, The Netherlands.

ORCID-Profile: Evi Banken, Davy M J Creemers

Förderung

  • ZonMw

Zitieren

APA

Banken, E., Geubels, B. M., Vande Kerckhove, F. E. C., Creemers, D. M. J., Ketelaers, S. H. J., Nederend, J., Peulen, H. M. U., van Hellemond, I. E. G., Rutten, H. J. T., & Burger, J. W. A. (2025). Watch-and-wait approach in high-risk locally advanced rectal cancer: outcomes after complete response to total neoadjuvant therapy. BJS Open. https://doi.org/10.1093/bjsopen/zraf136

Vancouver

Banken E, Geubels BM, Vande Kerckhove FEC, Creemers DMJ, Ketelaers SHJ, Nederend J, et al. Watch-and-wait approach in high-risk locally advanced rectal cancer: outcomes after complete response to total neoadjuvant therapy. BJS Open. 2025. doi:10.1093/bjsopen/zraf136

BibTeX
@article{Banken2025,
  author = {Banken, Evi and Geubels, Barbara M and Vande Kerckhove, Fleur E C and Creemers, Davy M J and Ketelaers, Stijn H J and Nederend, Joost and Peulen, Heike M U and van Hellemond, Irene E G and Rutten, Harm J T and Burger, Jacobus W A},
  title = {Watch-and-wait approach in high-risk locally advanced rectal cancer: outcomes after complete response to total neoadjuvant therapy},
  journal = {BJS Open},
  year = {2025},
  doi = {10.1093/bjsopen/zraf136}
}
Kostenlos starten →